Form 4: Director Ita Brennan Sells Planet Labs Shares

Planet Labs PBC Director Ita M. Brennan sold 36,500 shares of Class A Common Stock via a pre-arranged 10b5-1 trading plan.

Summary

• Director Ita M. Brennan executed the sale of 36,500 shares of Planet Labs PBC (PL) Class A Common Stock.
• The transaction occurred on April 15, 2026, at a weighted average price of $33.9063 per share.
• The sale was conducted pursuant to a Rule 10b5-1 trading plan adopted on January 14, 2026.
• Following the transaction, the reporting person retains beneficial ownership of 264,158 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; the sale was pre-planned and does not necessarily reflect a change in the director's outlook on the company's long-term prospects.

Positives

• The sale was executed under a pre-established Rule 10b5-1 trading plan, which is a standard mechanism for insiders to sell stock without concerns regarding non-public information.

Negatives

• The transaction represents a reduction in the direct equity stake held by a member of the Board of Directors.

Risks

• Insider selling can sometimes be perceived by the market as a lack of confidence in future share price appreciation, though this was a planned divestment.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing, as it is a standard disclosure of insider transaction activity.

Management Comments

• The reporting person has committed to providing full information regarding the number of shares sold at each separate price point upon request by the SEC, the Issuer, or security holders.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a routine corporate governance practice in the aerospace and satellite imagery sector, often used by executives to manage personal liquidity and diversify portfolios.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for public company directors to avoid potential conflicts of interest or insider trading allegations.
• The volume of shares sold is consistent with typical director equity compensation liquidation patterns observed in mid-cap technology firms.

Stakeholder Impact

• Shareholders should note the reduction in insider holdings, though the use of a 10b5-1 plan mitigates concerns regarding market timing.

Next Steps

• The director will continue to hold the remaining 264,158 shares.
• Future transactions by the director will be disclosed in subsequent SEC filings as required.

Key Dates

Keywords

Planet Labs, PL, Insider Trading, Form 4, Director Sale, Equity Compensation